Hostname: page-component-848d4c4894-5nwft Total loading time: 0 Render date: 2024-05-04T00:36:48.173Z Has data issue: false hasContentIssue false
  • English
  • Français

Opioid Crisis in the US – Lessons from Western Europe

Published online by Cambridge University Press:  01 January 2021

Kerstin Noëlle Vokinger
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Columns: Health Policy Portal
Information
Journal of Law, Medicine & Ethics , Volume 46 , Issue 1: The Future of Informed Consent in Research & Translational Medicine: A Century of Law, Ethics & Innovation , Spring 2018 , pp. 189 - 190
Copyright
Copyright © American Society of Law, Medicine and Ethics 2018

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

About This Column

Aaron Kesselheim serves as the editor for Health Policy Portal. Dr. Kesselheim is the JLME editor-in-chief and director of the Program On Regulation, Therapeutics, And Law at Brigham and Women's Hospital/Harvard Medical School. This column features timely analyses and perspectives on issues at the intersection of medicine, law, and health policy that are directly relevant to patient care. If you would like to submit to this section of JLME, please contact Dr. Kesselheim at akesselheim@bwh.harvard.edu

References

Volkow, M.D., and McLellan, A.T., “Opioid Abuse in Chronic Pain — Misconceptions and Mitigation Strategies,” New England Journal of Medicine 374 (2016): 1253–1263.Google Scholar
Sarpatwari, A., Sinha, M.S., and Kesselheim, A.S., “The Opioid Epidemic: Fixing a Broken Pharmaceutical Market,” Harvard Law and Policy Review 11, no. 2 (2017):463–484.Google Scholar
van Amsterdam, J. and van den Brink, W., “The Misuse of Prescription Opioids: A Threat for Europe?” Current Drug Abuse Review 8, no. 1 (2015): 3–14.CrossRefGoogle Scholar
Federal Office for Public Health, “Treatment of opioid disorder,” available at <https://www.bag.admin.ch/bag/de/home/themen/mensch-gesundheit/sucht/suchtberatung-therapie/substitutionsgestuetzte-behandlung.html> (last visited February 8, 2018).+(last+visited+February+8,+2018).>Google Scholar
Sarpatwari, A., Sinha, M.S., and Kesselheim, A.S., “The Opioid Epidemic: Fixing a Broken Pharmaceutical Market,” Harvard Law and Policy Review 11, no. 2 (2017): 463–484.Google Scholar
Federal Office for Public Health. supra note 4.Google Scholar
Available at <http://www.drogenbeauftragte.de/themen/suchtstoffeund-abhaengigkeiten/heroin/substitution.html> (last visited February 8, 2018).+(last+visited+February+8,+2018).>Google Scholar
Federal Office for Public Health, supra note 4.Google Scholar
Federal Office for Public Health, supra note 4.Google Scholar
Sinha, M. S., Kesselheim, A. S., Darrow, J. J., “Pharmaceutical Advertising in Medical Journals Revisiting a Long Standing Relationship,” CHEST 153, no. 1 (2018): 9–11.CrossRefGoogle Scholar
A. Sarpatwari et al., supra note 2.Google Scholar
Art. 33(1) Federal Act on Medicinal Products and Medical Devices.Google Scholar
Available at <http://www.spiegel.de/wissenschaft/medizin/korruptionaerztekammern-haben-fast-1000-verfahren-eingeleitet-a-877205.html> (last visited February 8, 2018).+(last+visited+February+8,+2018).>Google Scholar